SAPAP2 inhibitors are a class of chemical compounds that target and inhibit the function of Synapse Associated Protein 90/Postsynaptic Density-95 Associated Protein 2 (SAPAP2), a scaffolding protein involved in synaptic structure and signaling pathways. SAPAP2 belongs to the SAPAP family of proteins, which are critical components of the postsynaptic density in neurons, where they interact with other proteins such as PSD-95 and Shank to maintain the structural integrity and functionality of synapses. These inhibitors typically work by disrupting the protein-protein interactions mediated by SAPAP2 or by altering its ability to bind with other synaptic proteins, thus modulating the synaptic architecture and signaling efficiency. The regulation of SAPAP2 activity is of great interest in understanding the molecular mechanisms governing synaptic plasticity, which is fundamental to processes like learning and memory.
Chemically, SAPAP2 inhibitors may vary in structure depending on their specific mode of inhibition, whether it be competitive inhibition at the binding sites of SAPAP2 or non-competitive interactions that affect the protein's conformation. Some SAPAP2 inhibitors are designed to mimic the natural ligands or binding partners of SAPAP2, thereby blocking its normal interactions, while others may induce conformational changes that destabilize its role in the synaptic network. The development of SAPAP2 inhibitors often involves the identification of key residues involved in protein-protein interactions, followed by the design of small molecules or peptides that can effectively interfere with these sites. The molecular specificity and precision with which SAPAP2 inhibitors act make them valuable tools in dissecting the biochemical pathways that regulate synaptic dynamics and neuron-to-neuron communication at a fundamental level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Memantine hydrochloride | 41100-52-1 | sc-203628 | 50 mg | $69.00 | 4 | |
Another NMDA receptor antagonist, used in neurological conditions. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Inhibits L-type calcium channels, affecting calcium-dependent processes in neurons. | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $53.00 $94.00 $135.00 | 7 | |
Modulates calcium channels, potentially influencing neuronal signaling. | ||||||
(±)-Baclofen | 1134-47-0 | sc-200464 sc-200464A | 1 g 5 g | $56.00 $258.00 | ||
Activates GABA-B receptors, potentially modulating synaptic activity. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $318.00 | 9 | |
A selective serotonin reuptake inhibitor, studied in the research of various psychiatric conditions. | ||||||